Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Impaired adipogenesis and lipid storage capacity in subcutaneous adipose tissue of patients with PMOS
Adeline Divoux, Edina Erdos, Katie L. Whytock, Timothy F. Osborne, Steven R. Smith
Adeline Divoux, Edina Erdos, Katie L. Whytock, Timothy F. Osborne, Steven R. Smith
View: Text | PDF
Research Article Cell biology Metabolism

Impaired adipogenesis and lipid storage capacity in subcutaneous adipose tissue of patients with PMOS

  • Text
  • PDF
Abstract

Women with PMOS (formally termed PCOS) have an overall increased prevalence of metabolic syndrome (MetS) and central obesity. To help determine whether there might be changes in s.c. adipose tissue (SAT) associated with these abnormalities, we performed single-nuclei and scRNA-seq on SAT biopsies from 15 premenopausal PMOS women with signs of insulin resistance and 17 healthy BMI-matched controls. In SAT from PMOS versus control we observed a higher ratio of fibrotic versus insulin sensitive adipocytes and a higher ratio of mesenchymal stem cells (MSCs) to preadipocytes. Further in silico analysis suggested that preadipocytes in PMOS are more inflammatory and have a reduced capacity for differentiation. Slit homolog 2 (SLIT2), which is expressed at higher levels in MSC from PMOS, decreased adipogenesis in cell culture assays likely through its interaction with the Roundabout homolog 1 and homolog 2 (ROBO1/2) receptor expressed on the surface of preadipocytes. These new observations are consistent with higher SLIT/ROBO signaling, leading to reduced differentiation in the SAT of PMOS as an underlying mechanism for the aberrant ectopic fat accumulation and the development of MetS in PMOS.

Authors

Adeline Divoux, Edina Erdos, Katie L. Whytock, Timothy F. Osborne, Steven R. Smith

×

Figure 2

A single nuclei atlas of ABD and GF-AT in women with PMOS and BMI-matched women without PMOS.

Options: View larger image (or click on image) Download as PowerPoint
A single nuclei atlas of ABD and GF-AT in women with PMOS and BMI-matche...
(A) UMAP projection of clusters formed by 11,638 human single nuclei isolated from ABD and GF-AT. n = 5 PMOS and 5 CTRL. The dotplot shows the marker genes used to identify each cluster. (B) Dotplot representation of relative expression of genes identified by Strieder-Barboza et al. (34) in each cell cluster. FA, Fibro Adipogenic Adipose Stem Cell; IML, Inflammatory Mesothelial like Adipose Stem Cell (34). (C) Stacked bar charts show the repartition of each cluster in CTRL and PMOS samples, split by depot (ABD and GF). (D) Intersection plots show the genes upregulated in CTRL and in PMOS that are common or unique to each cluster (MSC, preadipocytes, adipocytes). The analysis was performed independently in ABD (top graph) and GF-AT (lower graph). (E) Dotplot representation of functional enrichment analysis using Hallmark on the genes differentially regulated between CTRL and PMOS in each cell clusters. Pink indicates the pathways enriched in PMOS samples; green indicates the pathways enriched in CTRL samples. See also Supplemental Figure 1. Overlap represents the number of genes in pathways. (F) Scatter plot showing the proportions of each cell clusters in ABD and GF-AT estimated by deconvolution analysis using RNA-seq data from 17 CTRL women and 15 women with PMOS (including the 10 subjects used for snRNA-seq analysis). See also Supplemental Figure 1.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts